LENSAR Inc
NASDAQ:LNSR
LENSAR Inc
Revenue
LENSAR Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LENSAR Inc
NASDAQ:LNSR
|
Revenue
$42.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is LENSAR Inc's Revenue?
Revenue
42.2m
USD
Based on the financial report for Dec 31, 2023, LENSAR Inc's Revenue amounts to 42.2m USD.
What is LENSAR Inc's Revenue growth rate?
Revenue CAGR 5Y
12%
Over the last year, the Revenue growth was 19%. The average annual Revenue growth rates for LENSAR Inc have been 17% over the past three years , 12% over the past five years .